Granules India Limited Drug For Further Processing
NDC Database
Granules India Limited Drug For Further Processing
NDC Database
National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.
- Total Records 53
- Latest Marketing Date 2025-12-26
- Data Source FDA
- First Marketing Date 2009-05-12
Company Overview
Company
Granules India Limited Drug For Further Processing
Country
India
Website
Social Profiles
Company Snapshot
Granules India Limited Drug For Further Processing
2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)
India
granulesindia.com/ mail@granulesindia.com View on MapNDC Records ( 53 records )
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-06
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Dapagliflozin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DAPAGLIFLOZIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Panadol Optizorb Granulate
Dosage Form
GRANULE
Strength
603 mg/10001
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-09-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Avatrombopag Maleate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AVATROMBOPAG MALEATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-03-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
acetaminophen extra strength red
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen Extra Strength
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-02
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Acetaminophen Directly compressible granules 90%
Dosage Form
POWDER
Strength
90 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-10-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Compresso PAP 90 CPF
Dosage Form
POWDER
Strength
90 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-08-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin HCl
Dosage Form
POWDER
Strength
97 mg/100mg
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-07-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen
Dosage Form
CAPSULE, GELATIN COATED
Strength
499.5 mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-10-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Compresso PAP 90 CPC
Dosage Form
POWDER
Strength
90 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-11-05
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Acetaminophen Directly compressible granules 90%
Dosage Form
POWDER
Strength
90 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen Directly compressible granules 90%
Dosage Form
POWDER
Strength
89.605 mg/89.605mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-10-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
acetaminophen
Dosage Form
TABLET, EXTENDED RELEASE
Strength
650 mg/1
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen Directly compressible granules 66%
Dosage Form
POWDER
Strength
66 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-02-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
COMPRESSO IBU 85 PAR
Dosage Form
POWDER
Strength
85 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-11-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen Directly compressible granules 66%
Dosage Form
POWDER
Strength
66 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-09-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-01-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Compresso MF 95P
Dosage Form
POWDER
Strength
95 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hcl
Dosage Form
POWDER
Strength
500 mg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin-Hcl
Dosage Form
POWDER
Strength
750 mg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin Directly compressible granules 95%
Dosage Form
POWDER
Strength
95 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GUAIFENESIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin Directly compressible Granules 95%
Dosage Form
POWDER
Strength
95 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GUAIFENESIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-05-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen and Ibuprofen
Dosage Form
TABLET
Strength
250; 125 mg/1; mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen 80% and Diphenhydramine Hcl 4% Directly compressible granules
Dosage Form
POWDER
Strength
80; 4 mg/100mg; mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-02-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trazodone Hydrochloride (Common Lubricated Blend)
Dosage Form
GRANULE
Strength
0.05 kg/kg
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
TRAZODONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-12-24
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Fexofenadine Hydrochloride
Dosage Form
TABLET
Strength
180 mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FEXOFENADINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen and Diphenhydramine Hydrochloride
Dosage Form
TABLET
Strength
500; 25 mg/1; mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-12-05
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Acetaminophen and Diphenhydramine Hydrochloride
Dosage Form
CAPSULE
Strength
500; 25 mg/1; mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-01-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Compresso PAP 90CPF
Dosage Form
POWDER
Strength
90 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Methocarbomal Granules DC 90%
Dosage Form
POWDER
Strength
90 mg/100mg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METHOCARBAMOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Compresso MF 95P
Dosage Form
POWDER
Strength
95 mg/100mg
Labeler
Granules India Limited
Marketing Category
EXPORT ONLY
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-10-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Potassium chloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
POTASSIUM CHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-05-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium Tabs 25 mg, 50 mg and 100mg (common blend)
Dosage Form
GRANULE
Strength
0.0333 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-04-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
TABLET, FILM COATED
Strength
220 mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-03-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
TABLET, FILM COATED
Strength
220 mg/1
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-03-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paracetamol
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-06-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium Trihydrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-07-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levetiracetam
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVETIRACETAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-07-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Viloxazine Hydrochloride
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VILOXAZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ruxolitinib Hydrochloride
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RUXOLITINIB HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ruxolitinib Phosphate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RUXOLITINIB PHOSPHATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sodium Oxybate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SODIUM OXYBATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CI
Start Marketing Date
2025-12-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Potassium Oxybate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
POTASSIUM OXYBATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-12-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Calcium Oxybate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CALCIUM OXYBATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-12-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Magnesium Oxybate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Granules India Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MAGNESIUM OXYBATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-12-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atazanavir Sulfate
Dosage Form
POWDER
Strength
25 kg/25kg
Labeler
Granules India Ltd
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATAZANAVIR SULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ibuprofen
Dosage Form
TABLET, FILM COATED
Strength
400 mg/1
Labeler
Granules India Ltd
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ibuprofen
Dosage Form
TABLET, FILM COATED
Strength
600 mg/1
Labeler
Granules India Ltd
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ibuprofen
Dosage Form
TABLET, FILM COATED
Strength
800 mg/1
Labeler
Granules India Ltd
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
NDC Type Breakdown
53 total- Drug for Further Processing
Official Source
NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).
Visit FDA NDC DirectoryNDC Record Details Preview
Explore important National Drug Code information available in the records above.
NDC
62207-001
Nonproprietary Name
Cetirizine Hydrochloride
Labeler
Granules India Limited
Dosage Form
POWDER
FDA NDC Data
National Drug Code information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized NDC records
Create a New Buying Request
Fields marked with * are mandatory.